CIG
GILD icon

Cairn Investment Group’s Gilead Sciences GILD Stock Holding History

Cairn Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
21,247
-116
-0.5% -$15.3K 1.18% 28
2026
Q1 		$2.98M Sell
21,363
-385
-2% -$53.9K 1.48% 26
2025
Q4 		$2.67M Sell
21,748
-30
-0.1% -$3.65K 1.27% 30
2025
Q3 		$2.42M Sell
21,778
-505
-2% -$57.4K 1.1% 31
2025
Q2 		$2.47M Buy
22,283
+160
+0.7% +$17K 1.29% 28
2025
Q1 		$2.48M Sell
22,123
-156
-0.7% -$16.1K 1.4% 27
2024
Q4 		$2.06M Sell
22,279
-65
-0.3% -$5.85K 1.21% 29
2024
Q3 		$1.87M Sell
22,344
-479
-2% -$36.5K 1.04% 32
2024
Q2 		$1.57M Sell
22,823
-1,450
-6% -$96.8K 0.91% 34
2024
Q1 		$1.78M Sell
24,273
-200
-0.8% -$15.4K 1.02% 32
2023
Q4 		$1.98M Buy
24,473
+1,355
+6% +$105K 1.24% 25
2023
Q3 		$1.73M Buy
23,118
+3,485
+18% +$268K 1.15% 26
2023
Q2 		$1.51M Buy
19,633
+740
+4% +$59K 0.98% 30
2023
Q1 		$1.57M Buy
18,893
+20
+0.1% +$1.66K 1.09% 26
2022
Q4 		$1.62M Buy
18,873
+761
+4% +$60.3K 1.21% 28
2022
Q3 		$1.12M Sell
18,112
-3,340
-16% -$211K 0.9% 37
2022
Q2 		$1.33M Buy
21,452
+1,365
+7% +$84.5K 1.03% 35
2022
Q1 		$1.54M Buy
20,087
+1,125
+6% +$71.9K 0.97% 37
2021
Q4 		$1.38M Sell
18,962
-1,385
-7% -$95.4K 0.95% 35
2021
Q3 		$1.42M Buy
20,347
+2,475
+14% +$174K 1.05% 32
2021
Q2 		$1.23M Buy
17,872
+435
+2% +$29K 0.9% 37
2021
Q1 		$1.13M Sell
17,437
-1,595
-8% -$103K 0.94% 37
2020
Q4 		$1.11M Sell
19,032
-85
-0.4% -$5.13K 1.05% 35
2020
Q3 		$1.21M Buy
19,117
+625
+3% +$43.3K 1.28% 32
2020
Q2 		$1.42M Sell
18,492
-415
-2% -$31.8K 1.73% 23
2020
Q1 		$1.41M Buy
18,907
+10,415
+123% +$720K 2.1% 16
2019
Q4 		$551K Buy
+8,492
New +$553K 0.55% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cairn Investment Group's GILD Position: Q2 2026 in Review

Cairn Investment Group reduced its Gilead Sciences (GILD) stake by 0.54% in Q2 2026, selling an estimated $15.3K and leaving 21,247 shares worth $2.68M. The position accounts for 1.18% of the portfolio, ranked #28.

Cairn Investment Group first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.98M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cairn Investment Group held 21,247 shares of Gilead Sciences worth $2.68M as of Q2 2026.
  • Cairn Investment Group sold 116 Gilead Sciences shares in Q2 2026, an estimated $15.3K.
  • Gilead Sciences made up 1.18% of Cairn Investment Group's portfolio in Q2 2026, its #28 holding.
  • Cairn Investment Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Cairn Investment Group's Gilead Sciences position peaked at $2.98M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cairn Investment Group's 13F filing for Q2 2026, filed 28 Jul 2026.